Physician profile
Marian Mocanu
NPI 1770768038
$1,138.74
in general payments reported to CMS, 2019-2025
17 companies · $76.85 in 2025
The $76.85 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $143 · 2021: $245 · 2022: $340 · 2023: $51.17 · 2024: $53.30 · 2025: $76.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $181.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $409.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $151.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $79.50 | 2019 | |
| Boston Scientific Corporation | $59.65 | 2021-2025 | Varithena Administration Pack, Ingevity+ |
| Abbott Laboratories | $53.65 | 2022-2024 | Amplatzer |
| Edwards Lifesciences Corporation | $46.27 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $40.83 | 2019-2023 | Lifevest |
| Cleerly, INC. | $34.10 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.62 | 2020 | |
| Cardiva Medical, INC. | $27.26 | 2023 | Cardiva Vascade 6/7f Vcs |
| Cardinal Health 200 LLC | $24.14 | 2021 | |
| Cordis US Corp. | $18.90 | 2025 | Mynx Control Venous |
| Lundbeck LLC | $16.52 | 2019 | |
| Amgen INC. | $15.36 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $14.59 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $13.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marian Mocanu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.